How to take it

Sodium Chloride

0.9 & Glucose 5 Infusion 4.

Possible side effects

5.

Possible side effects

. These side effects will depend on

the medicine that has been added.

y-39-o2-265

Reporting of side effects If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. If any side effects occur, the infusion must be stopped. You can also report side effects directly (see details below). By reporting side effects you can help provide more information on the safety of this medicine. United Kingdom: Via the Yellow Card Scheme at: www. mhra.gov.uk/yellowcard Malta ADR Reporting Website: www.medicinesauthority. gov.mt/adrportal Ireland: HPRA Pharmacovigilance, Earlsfort Terrace,

IRL – Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517. Website: www.hpra.ie; E-mail: [email protected].

SMMC eye Chloride 0.9 & Glucose 5 Infusion Keep this medicine out of the sight and reach of children. Sodium Chloride 0.9 & Glucose 5 Infusion does not

require special storage conditions. Sodium Chloride 0.9 & Glucose 5 Infusion should NOT be given to you after the expiry date which is stated on the bag after EXP. The expiry date refers to the last day of that month. You should not be given Sodium Chloride 0.9 & Glucose 5 Infusion, if there are particles floating in the solution or if the unit is damaged in any way.

6. Contents of the pack and Ua

Le

What Sodium Chloride 0.9 & Glucose 5 Infusion contains The active substances are:

e

sugar (glucose): 50 g per litre

e

sodium chloride: 9 g per litre

The only other ingredient is water for injections.

What Sodium Chloride 0.9 & Glucose 5 Infusion looks like and contents of the pack Sodium Chloride 0.9 & Glucose 5 Infusion is a clear solution, free from visible particles. It is supplied

in polyolefin/polyamide plastic bags (Viaflo). Each bag is wrapped in a sealed, protective, outer plastic overpouch.

The bag sizes are: e 250ml ® 500 ml ® 1000 ml The bags are supplied in cartons. Each carton contains one of the following quantities: e 30 bags of 250 ml e 20 bags of 500 ml e 10 bags of 1000 ml e 12 bags of 1000 ml Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturers Marketing Authorisation Holder: United Kingdom Baxter Healthcare Ltd Caxton Way, Thetford, Norfolk, IP24 3SE United Kingdom Ireland and Malta Baxter Holding B.V. Kobaltweg 49, 3542CE Utrecht, Netherlands

Manufacturers In Ireland:

Manufacturers in Great Britain:

BaxterSA

Baxter SA

Boulevard René Branquart, 80

Boulevard René Branquart,80

7860 Lessines

Baxter Healthcare Ltd.

Cira de Biescas, Senegiié

Caxton Way, Thetford Norfolk IP24 3SE United Kingdom Bieffe Medital Sabifianigo Ctra de Biescas, Senegiié 22666 Sabifianigo (Huesca) Spain

22666 Sabifianigo (Huesca) Spain

7860 Lessines Belgium

Belgium Bieffe Medital Sabifianigo

This leaflet was revised May 2025 For information about Sodium Chloride 0.9 & Glucose 5 Infusion or to request this leaflet in formats such as audio or large print please contact the Marketing Authorisation Holder: Tel: +44 (0)01635 206345.

Baxter and Viaflo are trademarks of Baxter International Inc.

flo TH-30-02-265

>s

You should read the Package Leaflet of the added medicine for a list of possible symptoms.

Baxter Sodium Chloride 0.9% w/v & Glucose 5% w/v Solution for Infusion BP The following information

immediately and not stored.

is intended for healthcare

Paediatric population In order to avoid potentially fatal over infusion of intravenous fluids to the neonate, special attention needs to be paid to the method of administration. When using a syringe pump to administer intravenous fluids or medicines to neonates, a bag of fluid should not be left connected to the syringe.

professionals only:

>s

Handling and Preparation Use only if the solution is clear, without visible particles and if the container is undamaged. Administer immediately following the insertion of infusion set. Do not remove unit from overwrap until ready for use. The inner bag maintains the sterility of the product. Do not use plastic containers in series connections. Such use could result in air embolism due to residual air being drawn from the primary container before the administration of the fluid from the secondary container is completed. Pressurizing intravenous solutions contained in flexible plastic containers to increase flow rates can result in air embolism if the residual air in the container is not fully evacuated prior to administration. Use of a vented intravenous administration set with the vent in the open position could result in air embolism. Vented intravenous administration sets with the vent in the open position should not be used with flexible plastic containers. The solution should be administered with sterile equipment using an aseptic technique. The equipment should be primed with the solution in order to prevent air entering the system. Additives may be introduced before infusion or during infusion through the re-sealable medication port. When additive is used, verify tonicity prior to parenteral administration. Thorough and careful aseptic mixing of any additive is mandatory. Solutions containing additives should be used

When using an infusion pump all clamps on the intravenous administration set must be closed before removing the administration set from the pump, or switching the pump off. This is required regardless of whether the administration set has an anti free flow device. The intravenous infusion device and administration equipment must be frequently monitored. Discard after single use. Discard any unused portion. Do not reconnect partially used bags.

1. Opening a. b.

c.

Remove the Viaflo container from the overpouch just before use. Check for minute leaks by squeezing inner bag firmly. If leaks are found, discard solution, as sterility may be impaired. Check the solution for limpidity and absence of foreign matters. If solution is not clear or contains foreign matters, discard the solution.

2. Preparation for administration Use sterile material for preparation and administration. a. Suspend container from eyelet support. b. Remove plastic protector from outlet port at bottom of container: grip the small wing on the neck of the port with one hand, grip the large wing on the cap with the other hand and twist, TH-30-02-265

d.

3.

the cap will pop off. Use an aseptic method to set up the infusion. Attach administration set. Refer to complete directions accompanying set for connection, priming of the set and administration of the solution.

Techniques for injection of additive medications

Warning: Additives may be incompatible (see Paragraph 5 "Incompatibilities of additive medications" below). To add medicinal products before administration a. Disinfect medication port. b. Using syringe with 19 gauge (1.10 mm) to 22 gauge (0.70 mm) needle, puncture resealable medication port and inject. c. Mix solution and medication thoroughly. For high-density medication such as potassium chloride, tap the ports gently while ports are upright and mix. Caution: Do not store bags containing added medications. To add medication during administration a. Close clamp on the set. b. Disinfect medication port. c. Using syringe with 19 gauge (1.10 mm) to 22 gauge (0.70 mm) needle, puncture resealable medication port and inject. d. Remove container from IV pole and/or turn to an upright position. e. Evacuate both ports by tapping gently while the container is in an upright position. f. Mix solution and medication thoroughly. g. Return container to in use position, re-open the clamp and continue administration.

4.

at 2 to 8°C unless dilution has taken place in controlled and validated aseptic conditions.

5. Incompatibilities of additive medications As with all parenteral solutions, before adding medications, compatibility of these additives with the solution in Viaflo container must be assessed. It is the responsibility of the physician to judge the incompatibility of an additive medication with the Sodium Chloride 0.9 & Glucose 5 Infusion by checking for eventual colour change and/or eventual appearance of precipitate, insoluble complexes or crystals. The Instructions for Use of the medication to be added must be consulted. Before adding a drug, verify it is soluble and stable in water at the pH of Sodium Chloride 0.9 & Glucose 5 Infusion (pH 3.5 – 6.5). When a compatible medication is added to the Sodium Chloride 0.9 & Glucose 5 Infusion, the solution must be administered immediately. As a guidance the following medications are incompatible with the Sodium Chloride 0.9 & Glucose 5 Infusion (non-exhaustive listing): e Ampicillin sodium e Mitomycin e Amphotericin B e Erythromycin lactobionate. Because of the presence of glucose, Sodium Chloride 0.9 & Glucose 5 Infusion should not be administered through the same infusion equipment as whole blood, as haemolysis and clumping can occur. Those additives known to be incompatible should not be used.

In-use shelf-life: Additives

The chemical and physical stability of any additive at the pH of Sodium Chloride 0.9 & Glucose 5 Infusion in the Viaflo container should be established prior to use. From a microbiological point of view, the diluted product must be used immediately. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours

Baxter and Viaflo are trademarks of Baxter International Inc.

Wento TH-30-02-265

SHE ——–2-2 22 eee

c.

Contents of the pack and other information

2. What you need to know HTM UTM NSS TLL Chloride 0.9 & Glucose 5 Infusion Do NOT receive Sodium Chloride 0.9 & Glucose 5 Infusion if you are suffering from any of the following conditions e

when you know you are allergic to the product

e

when there is too much fluid

TH-30-02-265

e

e e

e¢

e e e e e

e

in the spaces around the cells of the body (extracellular hyperhydration) when there is a larger volume of blood in the blood vessels than there should be (hypervolaemia) more fluid and sodium than normal in the body (fluid and sodium retention) severe kidney problems that mean you produce less urine than usual or none at all (oliguria or anuria) uncompensated heart failure. This is heart failure that is not adequately treated and causes symptoms such as: Shortness of breath swelling of the ankles higher levels of sodium in the blood than normal (hypernatraemia) higher levels of chloride in the blood than normal (hyperchloraemia) build up of fluid under the skin, affecting all parts of the body (general oedema) liver disease that causes fluid to build up within the abdomen (ascitic cirrhosis) diabetes that is not adequately treated, allowing your blood sugar levels to rise above normal (uncompensated diabetes) other states of glucose intolerance, for example: metabolic stress (when the body's metabolism does not function correctly, e.g. due to severe illness) hyperosmolar coma (unconsciousness). This is a type of coma that can occur if you have diabetes and do not receive enough medicine. avery high amount of sugar in the blood (significant hyperglycaemia) higher levels of lactate in the blood than normal (hyperlactataemia)

Warnings and precautions Please tell your doctor if you have or have had any of the following medical conditions: e adisorder in which the blood becomes too alkaline (metabolic alkalosis) e muscle weakness and periodic paralysis due to low thyroid activity (thyrotoxic periodic paralysis)

rapid loss of water from the body e.g. due to vomiting or diarrhoea being on a low potassium diet for a long time taking certain medications, see below: "Other medicines and Sodium Chloride 0.9 & Glucose 5 Infusion" a disorder in which the blood becomes too acidic (metabolic acidosis) if you have a condition that could cause high levels of vasopressin, a hormone regulating fluid in your body. You may have too much vasopressin in your body because, for example,

• you have had a sudden and serious illness,
• you are in pain,
• you have had surgery,
• you have infections, burns, brain disease diseases linked to your heart, liver, kidneys or central nervous system, because you are taking certain medicines (see also below "other medicines and Sodium Chloride 0.9 & Glucose 5 Infusion") This may increase the risk of low levels of sodium in your blood and can lead to headache, nausea, seizures, lethargy, coma, swelling of the brain and death. Brain swelling increases the risk of death and brain damage. People who are at higher risk of brain swelling are: children women (particularly if you are of a fertile age) people who have problems with their brain fluid levels, for example, because of meningitis, bleeding in the skull or a brain injury. Conditions associated with sodium retention, fluid overload and oedema, such as: aldosteronism (a disease that causes high levels of a hormone called aldosterone) associated with: –

–

poor liver function or liver disease that causes fluid to build up within the abdomen (ascitic cirrhosis) high blood pressure

(hypertension)

TH-30-02-265

heart failure poor kidney function e high blood pressure during pregnancy (preeclampsia) e any other condition associated with sodium retention (when the body retains too much sodium), such as treatment with steroids (see also below, "Other medicines and Sodium Chloride 0.9 & Glucose 5 Infusion") e allergy, in particular to corn (Sodium Chloride 0.9 & Glucose 5 Infusion contains sugar derived from corn) The infusion may cause: e changes in the concentrations of the chemicals in the blood (electrolyte disturbances) e build up of fluid under the skin, affecting all parts of the body (general oedema), around the ankles (peripheral oedema) or in the lungs (pulmonary oedema) e¢ ahigher amount of sugar in the blood than normal (hyperglycaemia) When you are given this infusion, your doctor will take blood and urine samples to monitor: e the amount of chemicals such as sodium and chloride in your blood (your plasma electrolytes) e the amount of sugar (glucose) As Sodium Chloride 0.9 & Glucose 5 Infusion contains sugar (glucose), it can cause a high level of sugar in the blood (hyperglycaemia). If this occurs, your doctor may: © adjust the speed of infusion e give you insulin to reduce the blood sugar levels This is particularly important: e if you are diabetic e if you have not been eating well or have been drinking too much alcohol for a long time e if you have recently had a stroke (acute ischaemic stroke). High levels of sugar in the blood can worsen the effects of stroke and affect recovery e if you have had head injury within the past 24 hours Your doctor will take into account if you are receiving parenteral nutrition (nutrition given by

infusion into a vein). During long-term treatment with Sodium Chloride 0.9 & Glucose 5 Infusion, you may need to be given extra nutrition. Your doctor should also monitor the level of potassium in your blood to avoid this becoming lower than normal (hypokalaemia).

Children Special care should be taken when giving this solution to children, infants, and newborns (especially premature babies and those with low birth weight). Children, infants and newborns may not have a good ability to handle the chemicals in the solution. Newborns – especially those born premature and with low birth weight – are at increased risk of developing a too low or too high level of sugar in the blood (hypo- or hyperglycaemia) and therefore need close monitoring during treatment with intravenous solutions containing glucose to ensure adequate control of the sugar levels in order to avoid potential long term adverse effects. Low sugar levels in newborns can cause prolonged seizures, coma and brain damage. High sugar levels have been associated with bleeding into the brain, late onset bacterial and fungal infection, damage to the eye (retinopathy of prematurity), infections in the intestinal track (necrotizing enterocolits), lung problems (bronchopulmonary dysplasia), prolonged hospital stay and death. Children are at higher risk for having or developing a too low sodium concentration in their blood (hyponatraemia). Hyponatraemia can lead to headache, nausea, seizures, lethargy, coma, swelling of the brain (cerebral oedema) and death. Acute hyponatraemic encephalopathy is a serious complication, especially in children. Your doctor knows this and will closely monitor the amount of chemicals such as sodium and chloride in your child's blood (plasma electrolytes).

Other medicines and Sodium Chloride

0.9 & Glucose 5 Infusion Tell your doctor if you are using, have recently used or might use any other medicines. It is particularly important that you inform your doctor if you are taking: TH-30-02-265

e

corticosteroids (anti-inflammatory medicines)

These medicines can cause the body to accumulate sodium and water, leading to: e tissue swelling due to fluid collection under the skin (oedema) e high blood pressure (hypertension) Some medicines act on the hormone vasopressin. These may include: e anti-diabetic medication (chlorpropamide) e cholesterol medicine (clofibrate) e some cancer drugs (vincristine, ifosfamide, cyclophosphamide) e selective serotonin reuptake inhibitors (used to treat depression) e antipsychotics or opioids for severe pain relief e medicines for pain and/or inflammation (also known as NSAIDs) e medicines that imitate or strengthen the effects of vasopressin such as desmopressin (used to treat increased thirst and urination) e terlipressin (used to treat bleeding of the gullet) and oxytocin (used to induce labour) e anti-epileptic medication (carbamazepine and oxcarbazepine) e diuretics (water tablets). Other medicines that can affect or be affected by Sodium Chloride 0.9/Glucose 5 Infusion: e lithium (used to treat psychiatric illnesses) e insulin (used to treat diabetes) e beta blockers (heart tablets) Sodium Chloride 0.9 & Glucose 5 Infusion must not be given through the same needle as a blood transfusion. This can damage the red blood cells or cause them to clump together.

Sodium Chloride 0.9 & Glucose 5

Infusion with food and drink You should ask your doctor about what you can eat or drink.

Pregnancy and breast-feeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or nurse for advice before taking this medicine.

Sodium Chloride 0.9 & Glucose 5 Infusion can be used during breastfeeding. If another medicine is to be added to your solution for infusion during pregnancy or breast-feeding you should: e consult your doctor e read the Package Leaflet of the medicine that is to be added.

Driving and using machines Sodium Chloride 0.9 & Glucose 5 Infusion does not affect your ability to drive or use machines.

SM

ems

mel

Sodium Chloride 0.9 & Glucose 5 Infusion You will be given Sodium Chloride 0.9 & Glucose 5 Infusion by a doctor or nurse. Your doctor will decide on how much you need and when it is to be given. This will depend on your age, weight, condition and the reason for treatment. The amount you are given may also be affected by other treatments you are receiving. You should NOT be given Sodium Chloride

0.9 & Glucose 5 Infusion if there are particles floating in the solution or if the pack is damaged in any way. Sodium Chloride 0.9 & Glucose 5 Infusion will usually be given to you through a plastic tube attached to a needle in a vein. However, your doctor may use another method to give you the medicine. Any unused solution should be thrown away. You should NOT be given an infusion of Sodium Chloride 0.9 & Glucose 5 Infusion from a bag that has been partly used. Before and during the infusion, your doctor will monitor: e the amount of fluid in your body e the acidity of your blood and urine e the amount of electrolytes in your body (particularly sodium, in patients with high levels of the hormone vasopressin, or are taking other medicines which increase the effects of vasopressin). P ) TH-30-02-265

If you receive more Sodium Chloride 0.9 & Glucose 5 Infusion than you should

of the added medicine for a list of possible symptoms.

If you are given too much Sodium Chloride 0.9 & Glucose 5 Infusion (over-infusion) or if it is given too fast, this may lead to the following symptoms:

Stop receiving your Sodium Chloride 0.9 & Glucose 5 Infusion

e

e

e

e

high levels of sugar in the blood (hyperglycaemia) Symptoms include: dry mouth due to lack of water in body tissues (dehydration)

• – thirst fatigue frequent urination due to increased urine production (osmotic diuresis) blurred vision low levels of sodium in the blood (hyponatraemia). Hyponatraemia can lead to headache, nausea, seizures, lethargy, coma, swelling of the brain (cerebral oedema) and death high blood levels of sodium (hypernatraemia). If this occurs, the most serious effect is a reduction in the water content of the brain (dehydration of the brain). This causes drowsiness and confusion and may lead to fits (convulsions), unconsciousness (coma), stopping breathing (respiratory failure) and even death. Other symptoms include: thirst dry mouth and eyes fever rapid heart rate (tachycardia) high blood pressure (hypertension) headache dizziness restlessness irritability weakness. build-up of fluid in the body causing swelling (oedema).

If you develop any of these symptoms you must inform your doctor immediately. Your infusion will be stopped and you will be given treatment depending on the symptoms. If a medicine has been added to your Sodium Chloride 0.9 & Glucose 5 Infusion before overinfusion occurs, that medicine may also cause symptoms. You should read the Package Leaflet

Your doctor will decide when to stop giving you this infusion. If you have any further questions on the use of

this product, ask your doctor or nurse.

4. Possible side effects Like all medicines, Sodium Chloride 0.9 & Glucose 5 Infusion can cause side effects, although not everybody gets them. The side effects can be related to Sodium Chloride 0.9 & Glucose 5 Infusion itself. This includes: e hypersensitivity reactions, including a serious allergic reaction called anaphylaxis (potential manifestation in patients with allergy to corn) e higher levels of sodium in the blood than normal (hypernatraemia) e higher levels of sugar in the blood than normal (hyperglycaemia) e low levels of sodium in the blood that may be acquired during hospitalization (nosocomial hyponatraemia) and related neurological disorders (acute hyponatremic encephalopathy). Hyponatraemia can lead to irreversible brain injury and death due to cerebral oedema/swelling (see also section 2 "Warnings and precautions"). The side effects can be related to the administration technique. This includes: e fever (febrile response) e chills e itching (pruritus) or rash e local pain or reaction (pain or vesicles at the site of infusion) e irritation and inflammation of the vein into which the solution is infused (phlebitis). This can cause redness, pain or burning and swelling along the path of the vein into which the solution is infused. If a medicine has been added to the solution for infusion, the added medicine may also cause